Cardiol Therapeutics Inc. - COM CL A (CRDL)

Historical Portfolio Holders from Q4 2019 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM CL A
Shares, excl. options Q1 2024
6.26 M
Holdings value Q1 2024
$11.3 M
Value change Q1 2024
+$51.6 K
Grand Portfolio weight change Q1 2024
+0%
Number of holders
29
Number of buys Q1 2024
10
Number of sells Q1 2024
-8
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
14161Y200
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 6.26 M $11.3 M +$51.6 K $1.81 29
2023 Q4 6.83 M $5.92 M +$428 K $0.84 30
2023 Q3 6.31 M $5.7 M -$336 K $0.90 29
2023 Q2 6.68 M $5.95 M -$452 K $0.89 28
2023 Q1 7.24 M $3.53 M +$205 K $0.49 29
2022 Q4 5.48 M $2.79 M +$221 K $0.51 25
2022 Q3 6.4 K $4 K -$58.7 K $0.71 3
2022 Q2 5.19 M $6.84 M -$80.1 K $1.32 22
2022 Q1 5.26 M $8.08 M -$1.07 M $1.54 22
2021 Q4 5.76 M $10.7 M +$7.69 M $1.85 26
2021 Q3 1.6 M $6.6 M +$6.6 M $4.14 18
2020 Q4 349 K $970 K +$171 K $2.78 1
2020 Q3 287 K $876 K +$133 K $3.05 1
2020 Q2 244 K $577 K +$78.3 K $2.37 1
2020 Q1 210 K $600 K +$50.7 K $2.85 1
2019 Q4 193 K $681 K $0 $3.53 1